Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6) (Q84947399)
Jump to navigation
Jump to search
scientific article published on 30 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6) |
scientific article published on 30 September 2012 |
Statements
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6) (English)
R E Pratley
D Urosevic
M Boldrin
R Balena
T-emerge 6 Study Group
30 September 2012